The harman and norharman reduced dopamine content and induced cytotoxicity in PC12 Cells

Biomolecules and Therapeutics

Volumn 16, Issue 2, 2008, Pages 106-112

  Yang, Yoo Jung ^a   Lim, Sung Cil ^a   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Dopamine content; Harman; Norharman; PC12 cell; Tyrosine hydroxylase

Indexed keywords

BETA CARBOLINE; CYCLIC AMP; DOPAMINE; HARMAN; LEVODOPA; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; IC 50; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHEOCHROMOCYTOMA CELL; RAT;

EID: 69549105760     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2008.16.2.106     Document Type: Article

References (34)

1. Albores, R., Neafsey, E.J., Drucker, G., Fields, J.Z. and Collins, M.A. (1990). Mitochondrial respiratory inhibition by N-methylated β-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc. Natl. Acad. Sci. USA. 87, 9368-9372. (Pubitemid 120030627)
2. Allen, J.R.F. and Holmstedt, B.R. (1980). The simple β-carboline alkaloids. Phytochem. 19, 1573-1582.
3. Breyer-Pfaff, U., Wiatr, G., Stevens, I., Gaertner, H.J., Mundle, G. and Mann, K. (1996). Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking. Life Sci. 58, 1425-1432. (Pubitemid 126352726)
4. Cohen, G. (1983). The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence. J. Neural Transm. 19(Suppl.), 89-103.
5. Deitrich, R. and Erwin, V. (1980). Biogenic amine-aldehyde condensation products: Tetrahydroisoquinolines and trytolines (β-carbolines). Annu. Rev. Pharmacol. Toxicol. 20, 55-80.
6. Ehringer, H. and Hornykiewicz, O. (1960). Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschr. 38, 1236-1239.
7. 2NH). Ann. N.Y. Acad. Sci. 648, 272-274.
8. Gearhart, D.A., Collins, M.A., Lee, J.M. and Neafsey, E.J. (2000). Increased brain β-carboline-9N-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol. Dis. 7, 201-211. (Pubitemid 30451034)
9. Goldstein, M. (1995). Long- and short-term regulation of tyrosine hydroxylase. In: Bloom F.E., Kupfer D.J. (Eds.), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, 189-195.
10. Green, S., Buttrum, S., Molloy, H., Steventon, G., Sturman, S., Waring, R., Pall, H. and Williams, A. (1991). N-methylation of pyridines in Parkinson's disease. Lancet 338, 120-121.
11. Kim, K.S., Park, D.H. and Joh, T.H. (1993). Parallel up-regulation of catecholamine biosynthesis enzymes by dexamethasone in PC12 cells. J. Neurochem. 60, 946-951. (Pubitemid 23066714)
12. Kim, Y.M., Kim, M.N., Lee, J.J. and Lee, M.K. (2005). Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 386, 1-4.
13. Kuhn, W., Muller, T., Grobe, H., Dierks, T. and Rommelapacher, H. (1995). Plasma levels of the β-carbolines harman and norharman in Parkinson's disease. Acta Neurol. Scand. 92, 451-454. (Pubitemid 3008315)
14. Kumer, S.C. and Vrana, K.E. (1996). Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443-462. (Pubitemid 26255637)
15. Lee, J.J., Kim, Y.M., Yin, S.Y., Park, H.D., Kang, M.H., Hong, J.T. and Lee, M.K. (2003). Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66, 1787-1795 (Pubitemid 37249323)
16. Lee, M.K. and Kim, H.S. (1996). Inhibitory effects of protoberberine alkaloids from the root of Coptis japonica on catecholamine biosynthesis in PC12 cells. Planta Med. 62, 31-34.
17. Lowry, O.H., Rosenbrough, N.L., Farr, A.L. and Randall, R.L. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
18. Marsden, C.D. (1994). Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 57, 672-681.
19. Matsubara, K., Collins, M.A., Akane, A., Ikebuchi, J., Neafsey, E.J., Kagawa, M. and Shiono, H. (1993). Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain. Brain Res. 610, 90-96. (Pubitemid 23144428)
20. May, T., Rommelspacher, H. and Pawlik, M. (1991). [2H]harman binding experiments: I. A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat. J. Neurochem. 56, 490-499. (Pubitemid 21901989)
21. McNaught, K.St.P., Carrupt, P.A., Altmore, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P. and Marsden, C.D. (1998). Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56, 921-933. (Pubitemid 28454556)
22. Migheli, R., Godani, C., Bciola, L., Delodu, M.R., Serra, P.A., Zangani, D., Natale, G.D., Miele, E. and Desole, M.S. (1999). Enhancing effect of managanese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J. Neurochem. 73, 1155-1163. (Pubitemid 29395474)
23. Nagatsu, T. (1997). Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29, 99-111. (Pubitemid 27422504)
24. Nagatsu, T., Oka, K. and Kato, K. (1979). Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr. 163, 247-252. (Pubitemid 9244668)
25. Neafsey, E.J., Drucker, G., Raikoff, K. and Collins, M.A. (1989). Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methy-4-phenylpyridinium ion (MPP+). Neurosci. Lett. 105, 344-349. (Pubitemid 19258900)
26. Pfau, W. and Skog, K. (2004). Exposure to β-carbolines norharman and harman. J. Chromatogr. B. 802, 115-126.
27. Sandstrom, P.A., Mannie, M.D. and Buttke, T.H. (1994). Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55, 221-226.
28. Shin, J.S., Kim, E.I., Kai, M. and Lee, M.K. (2000). Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25, 363-368. (Pubitemid 30161482)
29. Shin, J.S., Kim, K.T. and Lee, M.K. (1998). Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett. 244, 161-164. (Pubitemid 28226316)
30. Shin, J.S., Lee, J.J., Kim, Y., Lee, C.K., Yun, Y.P. and Lee, M.K. (2001). Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull. 24, 103-105. (Pubitemid 32125014)
31. Shin, J.S., Yun-Choi, H.S., Kim, E.I. and Lee, M.K. (1999). Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65, 452-455.
32. Tischler, A.S., Perlman, R.L., Morse, G.M. and Sheard, B.E. (1983). Glucocorticoids increase catecholamine synthesis and storage in PC12 cells pheochromocytoma cell culture. J. Neurochem. 40, 364-370.
33. Yin, S.Y., Kim, Y.M., Lee, J.J., Jin, C.M., Yang, Y.J., Ma, J.J., Kang, M.H., Kai, M. and Lee, M.K. (2004a). Enantio-selective inhibition of (1R,9S)- and (1S,9R)-β-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol. 47, 1045-1052. (Pubitemid 39535843)
34. Yin, S.Y., Lee, J.J., Kim, Y.M., Jin, C.M., Yang, Y.J., Kang, M.H., Kai, M. and Lee, M.K. (2004b). Effects of (1R,9S)-β-hydrastine on L-DOPA-induced cytotoxicity in PC12 cells. Eur. J. Pharmacol. 488, 71-77. (Pubitemid 38388525)